ABSTRACT
INTRODUCTION
Randomized controlled clinical trials in psychiatry are designed to evaluate the efficacy of an intervention [1, 2] [3] . However, the use of fMRI in evaluating treatment effects in psychiatry also involves a number of unique methodological considerations. Our purpose here is to outline important considerations to guide design decisions in the context of particular research questions. We have incorporated general experimental and methodological principles derived from our own fMRI intervention studies [4] [5] [6] [7] to guide investigations of treatment effects in psychiatric and neurodevelopmental disorders via fMRI.
. Such trials may rely on assessments of symptom severity, global functioning, and neurocognitive function as outcome measures. With the recent advent of functional brain imaging techniques, the opportunity exists to investigate the potential neurobiological mechanisms of action of interventions by comparing brain scans acquired before and after a particular treatment (or set of treatments). The use of cognitive neuroscience techniques, such as functional magnetic resonance imaging (fMRI), to address treatment effects represents a shift to a mechanistic approach to understanding not only disease states but also treatment effects and has the potential to reveal heretofore unknown neurobiological mechanisms of treatment effects. The evaluation of treatments via functional brain imaging more closely models early drug development and basic science approaches to screening new drug therapies and thus may promote swifter transition of agents to clinical trails

General Methodological Concerns
Psychometric Properties of Repeated fMRI Scans
Although a small handful of studies have examined pretreatment fMRI scans as predictors of treatment response [8] , the most common neuroimaging clinical trial design in psychiatry involves the collection of symptom and fMRI data from a patient group at least twice, once before the initiation of treatment and once after treatment course. Although far less common, additional fMRI scans may also be collected mid-way through the course of treatment as well as after treatment termination to investigate the timecourse of effects on brain activation. All of the above contexts require the collection of multiple fMRI scans from patients receiving treatment. Given the longitudinal nature of intervention studies, brain imaging methods for evaluating treatment mechanisms must meet the same psychometric properties as traditional "paper-and-pencil" outcome measures, including high test-retest reliability [9] , limited practice effects, and sensitivity to change [10] . Despite methodological advances in ways to assess the test-retest reliability of functional brain imaging data [11] [12] [13] , only recently have the psychometrics of repeated fMRI assessments been evaluated, with initial results suggesting high reliability in some studies [14] [15] [16] and low reliability in other studies [17] [18] [19] [20] . [16, 22, 23] [52] [53] [54] [55] .
Recommendations. Cognitive tasks, data acquisi
Heterogeneity of Treatment Response
In nearly all contexts, the effects of psychiatric interventions are highly heterogenous. [48, 49] [51] or modeled during fMRI data analyses [56] . However, caution is warranted because improved task performance may be related to intervention effects in unforeseen ways, and thus group matching or covariation may attenuate power to detect treatment effects on brain activation.
Psychopharmacologic Side Effects and Dosing
Recommendations. Side effects are common in psychopharmacologic trials, even amongst patients receiving blinded placebo treatments [27] .
Side effects that impact attention (e.g., dizziness, drowsiness) may affect task-related brain activation as well. Additionally, there may be differential effects on brain activation of differing medication dosages, even in the context of similar clinical benefits.
Recommendations. If sample sizes allow, secondary analyses should be conducted that subgroup patients on the basis of particular side effects profiles or by final medication dosage or that analyze only the subgroup of patients without significant side effects or with the same final medication dosage.
Considerations for fMRI Intervention Studies in Neurodevelopmental Disorders
Excessive [59] , and mathematical corrections for head motion are imperfect [60] . Further, signal changes due to motion may correlate with functional BOLD signal changes resulting in activation patterns that spuriously appear to be a function of the fMRI task [61] . Measures of heart rate and respiration should be collected and modeled during data analysis [62, 63] (see Figure 1) [70] . Volume FIGURE 
Recommendations. Minimizing participant motion is vital because task-related changes in BOLD signals are relatively small compared to motion-related changes in BOLD signal
Functional MRI (fMRI) activation maps depicting the effects of regression filtering to remove respiratory noise. The fMRI task is a simple hand sensorimotor task. This patient had a large left frontal glioblastoma and irregularity in his respiration pattern during the scan (A) that caused significant artifacts in the motor activation map (B)
. These artifacts were filtered out to produce a more specific motor function map (C). The noise removal was done using regression filtering implemented in fScan [63] based on the RETROICOR method of Glover and colleagues [90] .
differences have been identified in key neuroanatomic regions in numerous neurodevelopmental disorders, including autism [71] , Fragile X syndrome [72] , and Williams Syndrome [73] .
Recommendations. Normalization to standard stereotaxic space in fMRI treatment studies of neurodevelopmental disorders should be done with caution. When differences in brain morphology have been documented, regional mean signal change analyses performed in native subject space may be optimal [60, 74] . An additional consideration is that, although most fMRI studies test for regional differences in MR signal intensity, differences in brain morphometry may manifest in terms of the spatial extent, rather than magnitude, of brain activity [75] . Thus, effects of signal extent, as well as intensity, should be evaluated.
Analysis of Pediatric Neuroimaging Data. Although fMRI studies of neurodevelopmental disorders typically include pediatric samples [76, 77] , and nonclinical fMRI studies have been carried out even with infants [78] , best practices for the analysis of pediatric brain imaging data are still evolving [51] . Similar to cross-sectional pediatric functional brain imaging studies, researchers conducting pediatric treatment neuroimaging trials must decide whether to analyze pediatric brain imaging data using normalization to adult template brains, normalization to pediatric template brains, or in native space using either automated or expert manual segmentation.
Recommendations. Despite initial evidence that brain imaging data from children as young as 7 years old may be adequately normalized with adult brain templates [79, 80] the use of adult brain templates and atlases for normalization and segmentation pediatric brain imaging data may impose biases and limitations for estimates of both brain structure and brain function [81, 82] . Multiple pediatric brain templates and pediatric brain scan data repositories are available [81, [83] [84] [85] [86] . These templates allow for automated analytic procedures with accurate spatial normalization for adults and children. Additionally, there is initial evidence that study-specific "internal" or "local" Figure 2 [88, 89] . One participant (Case [7] . FIGURE 3. Figure 3 illustrates results from an antidepressant treatment fMRI trial [5, 6] . Outpatients with unipolar major depressive disorder participated in a pretreatment fMRI scans that utilized a Wheel of Fortune decision-making and reward processing task [Ernst, 2004] Figure 4 illustrates the effects of psychotherapy on brain responses during reward anticipation in the same group of outpatients with unipolar depression [5] [5] . 
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